European Archives - Page 1017 of 1049 - European Medical Journal

EMJ Dermatology 2014

Welcome to the new edition of the European Medical Journal Dermatology. We have combined leading, peer-reviewed editorials with reviews from the European…

EMJ

Immune Checkpoint Inhibitors May Work in Brain Cancers

LUGANO/GENEVA, Switzerland, 21 November 2014 – New evidence that immune checkpoint inhibitors may work in glioblastoma and brain metastases was presented…

EMJ

Possibilities for Personalised Vaccines Revealed at ESMO Symposium

LUGANO/GENEVA, Switzerland, 21 November 2014 – The possibilities for personalised vaccines in all types of cancer are revealed today in a lecture from…

Extracellular Matrix Remodelling In COPD

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease that involves major remodelling of cells and tissue in the lung.

Sequential Androgen Receptor Pathway Inhibitor in Prostate Cancer: Piling-Up The Benefits or a Case for Cross-Resistance?

In the last 10 years, there has been accumulating evidence that, even in a low serum testosterone environment, the androgen receptor (AR) remains the…

Unmet Medical Needs in Non-Small-Cell Lung Cancer Treatment: How to Design Pre-Emptive Combination Therapies

The rapidly expanding catalogue of human oncogenic mutations, coupled with difficulties in identifying the cellular targets of active compounds in…

Women and Lung Cancer: Literature Assumptions and News from Recent Publications

For a long period of time, lung cancer (LC) was considered as a malignancy affecting only males, but epidemiological data have shown a dramatic increase…

Rituximab and Other New Anti-CD20 MAbs for Non-Hodgkin’s Lymphoma Treatment

Non-Hodgkin’s lymphomas (NHLs) are a heterogeneous group of different haematological cancers with a wide range of aggressiveness. NHLs represent >80% of….

Fundamental Principles of Raising an Antitumour Immune Response in Vivo: A Complex Model, a Case Report, and a Perspective

In preclinical model systems, the fundamental principles underlying a successful and durable anti-tumour immune response are well demonstrated.

Immunotherapy of Cancer: Towards a New Era

In the past two decades, immunotherapy of cancer has developed into an established treatment option. At first, the development of monoclonal antibodies…